Fresh Tracks Therapeutics Inc (FRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2020 | 12-2019 | 09-2019 | 06-2019 | 03-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,103 | -23,877 | -13,015 | -8,234 | -4,580 |
| Depreciation Amortization | 3 | 1,603 | 1,068 | 572 | 113 |
| Accounts payable and accrued liabilities | -1,108 | -1,822 | -2,776 | 3,053 | 2,521 |
| Other Working Capital | -2,938 | -13,630 | -9,111 | -2,311 | -1,002 |
| Other Operating Activity | 1,536 | 1,745 | 1,894 | -2,582 | -2,368 |
| Operating Cash Flow | $-6,610 | $-35,981 | $-21,940 | $-9,502 | $-5,316 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -7 | -8 | -4 | -2 |
| Net Acquisitions | N/A | 13,017 | 13,017 | N/A | N/A |
| Sale Of Investment | 4,500 | 19,500 | 5,500 | N/A | N/A |
| Investing Cash Flow | $4,500 | $32,510 | $18,509 | $-4 | $-2 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | N/A | -795 |
| Debt Issued | N/A | 7,397 | 7,397 | 5,127 | 1,315 |
| Debt Repayment | N/A | -4,808 | -4,808 | -1,609 | N/A |
| Common Stock Issued | 2,005 | 47 | N/A | N/A | N/A |
| Financing Cash Flow | $2,005 | $2,636 | $2,589 | $3,518 | $520 |
| Beginning Cash Position | 7,232 | 8,067 | 8,067 | 8,067 | 8,067 |
| End Cash Position | 7,127 | 7,232 | 7,225 | 2,079 | 3,269 |
| Net Cash Flow | $-105 | $-835 | $-842 | $-5,988 | $-4,798 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,610 | -35,981 | -21,940 | -9,502 | -5,316 |
| Capital Expenditure | N/A | -7 | -8 | -4 | -2 |
| Free Cash Flow | -6,610 | -35,988 | -21,948 | -9,506 | -5,318 |